<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>HNN215 Week 6 Padlet - 2pm by </title>
      <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0</link>
      <description>Management of patients experiencing GIT and endocrine dysfunction</description>
      <language>en-us</language>
      <pubDate>2023-04-12 00:57:23 UTC</pubDate>
      <lastBuildDate>2025-12-10 10:44:44 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Case Scenario</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876495</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/ac7a6c9b8139827b03455b03d72071a7/image.png" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876495</guid>
      </item>
      <item>
         <title>Scenario continued</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876496</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/e6d42c23a3883d7e909708645417f68b/image.png" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876496</guid>
      </item>
      <item>
         <title>Compare and contrast the mode of action of the drug classes</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876497</link>
         <description><![CDATA[<div>Did you find a simpler way to describe them?<br>Could you say in your own words what they are?<br>Did you need to go and look them up again? Do you need to rethink your explanation into your own words?</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876497</guid>
      </item>
      <item>
         <title>Significant risks / drug-drug interactions???</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876498</link>
         <description><![CDATA[<div>How / why does it occur?<br>What are they and what signs and symptoms would we see?<br>What do we as nurses do;<br>- prevent and/ or manage these?</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/b6952d65c81629da46baba70d3b4377f/image.png" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876498</guid>
      </item>
      <item>
         <title></title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876499</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/ab867eee34e35101fb3a63ab8cec9ec2/HNN215_week_6_NIMC_2023.pdf" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876499</guid>
      </item>
      <item>
         <title></title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876500</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/4bcc96adc7140d2ad53c7922845af09d/HNN215_Week_6_Insulin_chart_2023.pdf" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876500</guid>
      </item>
      <item>
         <title>Consider??? </title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876503</link>
         <description><![CDATA[<div><strong><mark>Note: Always consider:<br>Is there anything in the patient's condition/ past history that may increase the risks?</mark></strong></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876503</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876504</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876504</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876506</link>
         <description><![CDATA[<ul><li>Potential effects of the drug on milk production.</li><li>Amount of the drug excreted into human milk.</li><li>Extent of oral absorption by the breastfeeding infant.</li><li>Potential adverse effects on the breastfeeding infant.</li></ul><div><br>Warfarin therapy should be avoided <strong>at least during the first trimester (because of teratogenicity) and from about 2 to 4 weeks before delivery</strong> to reduce risk of hemorrhagic complications.<br><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876506</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876507</link>
         <description><![CDATA[<div>what steps should a nurse take prior to administering medications to a pregnant or breastfeeding pt?&nbsp;<br>- its your medication short-acting or long-acting?<br>short acting should be immediately taken after a nursing session while long acting should be taken just before your babies longest sleep period&nbsp;<br>- watch for baby if any reactions<br>-plasma drug calculations should be reduced in pregnancy&nbsp;<br>-provide an adequate therapeutic response <br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876507</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876508</link>
         <description><![CDATA[<div>1.<strong> What steps should the nurse take prior to administering medicines to a pregnant or breastfeeding patient? <br></strong>- Research medicines on AMH prior to administering to see advice in regards to pregnant and breastfeeding patients&nbsp;<br>- Monitor patient<br>- Taking lowest possible dose<br>- Take medicine straight after  a feed, or before baby is due for a long sleep </div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876508</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876509</link>
         <description><![CDATA[<div>- Avoiding using medications that are not necessary<br>- If the relevant infant dose is less than 10% most medications are relatively safe&nbsp;<br>- Choose drugs that have extensive research studies<br>- evaluate the infant for risks<br>- caution with premature or Neonates<br>- Meds used in the first 3 days generally produce subclinical level in the infant due to the limited volumes of milk&nbsp;<br>- Recommended that the mothers get treated for depression as most medication used is safe&nbsp;<br>- Discontinuing breastfeeding for some hours/day may be required<br>- Choose drugs with short half lives,  high protein binding, low oral bioavailability, or high molecular weight <br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876509</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876511</link>
         <description><![CDATA[<div>By looking at the URL of the website, if it ends in EDU or ORG it is definitly a more reliable source, However I would advise them to wait as i consult a doctor to determine if taking panadol would be acceptable. </div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876511</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876512</link>
         <description><![CDATA[<div>Web pages that are health organisation</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876512</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876513</link>
         <description><![CDATA[<div>Look at websites that end in .gov or .org rather than .com<br>Access AMH</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876513</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876514</link>
         <description><![CDATA[<div>Access AMH or MM to research whether it is safe on a reliable source</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876514</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876515</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876515</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876517</link>
         <description><![CDATA[<div>Optisulin<br>Class: insulin<br><br>MOA:<br>Increase or restore ability to metabolise glucose by enhancing cellular glucose uptake; inhibit endogenous glucose output and lipolysis.<br><br></div><div>Indications for use:<br>Diabetes mellitus, including type 1, type 2 or gestational diabetes<br><br>Nursing considerations:<br>- accidental overdose<br>- weight gain<br>- allergic reaction<br>- BGLs<br>- monitor food intake<br><br>Drug - drug interactions:<br>pioglitazone + insulin<br>Pioglitazone in combination with insulin increases risk of oedema and heart failure above that of pioglitazone alone; there may also be an increased risk of hypoglycaemia. Use combination cautiously; monitor blood glucose concentration and for signs of heart failure; consider reducing insulin dose if hypoglycaemia develops.</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876517</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876518</link>
         <description><![CDATA[<div>Novorapid<br>Class: fast-acting insulins and analogues&nbsp;<br><br>MOA: regulates the metabolism of glucose, produces a rapid onset 10-15minutes compared to soluble insulins<br><br>Indications for use: diabetes&nbsp;<br><br><br>Nursing considerations:<br>- Risk of hypoglycaemia, may occur with excessive dosage, delayed or insufficient food. Symptoms may include sweating, faintness, palpitation, tremor, headache, confusion, altered mood<br>- Allergic reactions, itching<br>-give immediately before meals<br><br>Drug - drug interactions:<br>antipsychotics, steroids, blood pressure medications</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876518</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876519</link>
         <description><![CDATA[<div>Gliclazide<br>Class: Sulfonylurea<br><br>MOA: increase secretion of insulin from the beta cells of the pancreas.&nbsp;<br>Also potentially decreases insulin resistance.<br><br>Indications for use: Type 2 Diabetes Mellitus. <br><br>Nursing considerations: a risk of hypoglycaemia due to an increase in insulin production and a decrease in insulin resistance. <br><br>Drug - drug interactions: use of sulfonylurea with fluconazole may increase the concentration of sulfonylurea and therefore increase the risk of hypoglycaemia. </div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876519</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876522</link>
         <description><![CDATA[<div>Metoclopramide<br>Class: Antiemetic&nbsp;<br><br>MOA: What is the mechanism of action of metoclopramide?</div><div>Metoclopramide promotes gut motility by the following three mechanisms: inhibition of presynaptic and postsynaptic D<sub>2</sub> receptors, stimulation of presynaptic excitatory 5-HT<sub>4</sub> receptors and antagonism of presynaptic inhibition of muscarinic receptors</div><div><br><br>Indications for use:<br><br>- Nausea and vomiting</div><div>- Gastric stasis (eg after gastric surgery, diabetic gastroparesis)</div><div>- Difficult small intestinal intubation<br><br></div><div><br>Nursing considerations:<br><br></div><ul><li>use short term only (maximum of 5 days); risk of tardive dyskinesia increases with cumulative dose and length of treatment</li><li>metoclopramide has been used for lactation stimulation but is not recommended due to safety and efficacy concerns; use non-pharmacological measures</li></ul><div><br>Drug - drug interactions:<br>Metoclopramide may inhibit metabolism of suxamethonium, increasing neuromuscular block and causing respiratory insufficiency; use cautiously, monitor respiratory function.</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876522</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876524</link>
         <description><![CDATA[<div>Mylanta/Omeprazole<br>Class: proton-pump inhibitors<br><br>MOA: Bind to the hydrogen/potassium ATPase enzyme system (proton pump), inhibiting both stimulated and basal acid secretion.<br><br>Indications for use: <br>Peptic ulcer disease (PUD)<br>GORD<br>Zollinger-Ellison syndrome<br><em>H. pylori</em> eradication, as part of an effective regimen<br><br></div><div>Nursing considerations - Advise patient to avoid alcohol and foods that may cause an increase in GI irritation.<br><br>Instruct patient to report about prolonged side effects, including skin problems (itching, rash) or GI effects (nausea, diarrhea, vomiting, constipation, heartburn, flatulence, abdominal pain).<br><br>Risk of electrolyte disturbances may be increased in the elderly<br><br>Drug - drug interactions: can interact with clopidogrel, warfarin, and certain HIV medications.<br><br><br>Mylanta -<br>Class - Antacids<br><br>MOA - Neutralize hydrochloric acid secreted by gastric parietal cells.<br><br>Indications for use - Symptomatic relief of dyspepsia, peptic ulcer disease and GORD<br><br>Nursing Considerations -&nbsp;<br><br><br>Drug Interactions - Avoid taking any other medicine within 2 hours before or 2 hours after you take aluminum hydroxide, magnesium hydroxide, and simethicon as it can make harder for your body to absorb other medicines.<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876524</guid>
      </item>
      <item>
         <title>Pregnant and breast feeding patients and medications</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876527</link>
         <description><![CDATA[<div>1.<strong> What steps should the nurse take prior to administering medicines to a pregnant or breastfeeding patient? </strong><br><br><strong>Look up the prescribed medications to see if they are safe to administer.<br></strong><em>Remember there may be an additional resource that you may want to access</em></div>]]></description>
         <enclosure url="https://image.slidesharecdn.com/issuestoconsiderwhileprescribingforpregnantandlactatingpatients-150928020407-lva1-app6892/95/issues-to-consider-while-prescribing-for-pregnant-and-lactating-patients-2-638.jpg?cb=1443405905" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876527</guid>
      </item>
      <item>
         <title>Final scenario part</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876528</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/985c41a0100b05e72916ad12b19c2fb1/image.png" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876528</guid>
      </item>
      <item>
         <title></title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876529</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/71befde868507b56c0cff24f8d0bc417/image.png" />
         <pubDate>2023-04-12 00:57:23 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/eh4tckzn7vzgxju0/wish/2550876529</guid>
      </item>
   </channel>
</rss>
